Alberta Investment Management Corp Xencor Inc Transaction History

Alberta Investment Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$36.63 - $47.63 $1.59 Million - $2.06 Million	-43,300 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$30.09 - $43.02 $460,377 - $658,206	-15,300 Reduced 26.11%	43,300 $1.68 Million
Q2 2020 Aug 11, 2020	BUY	$27.76 - $33.42 $385,864 - $464,538	13,900 Added 31.1%	58,600 $1.9 Million
Q1 2020 May 08, 2020	SELL	$20.69 - $37.79 $136,554 - $249,414	-6,600 Reduced 12.87%	44,700 $1.34 Million
Q4 2019 Feb 14, 2020	BUY	$32.75 - $41.43 $1.68 Million - $2.13 Million	51,300 New	51,300 $1.76 Million

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.